SOL stock
SOL.MIMILSOL S.p.A., Basic MaterialsISIN IT0001206769
68Score 68 out of 100, Neutral
Price and trend
78 / 100
Price history
+30% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 13% above it.
Since March 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Overheated: the price has risen very quickly lately (RSI 73).
The price is at its 52-week high. Largest decline in 20 years: 58% (May 2007 to December 2008).
Chart figures for advanced users
- SMA 50$63.96
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$62.63
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)73
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$50.52
- The lowest closing price of the last twelve months.
- Resistance$70.77
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- SOL S.p.A. belongs to the Chemicals (Specialty) industry (Italy) and, with a market value of $6.42B, is number 47 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $1.98B (up 10.3% year on year) and earnings of $185.81M (up 13.1%).
- For fiscal 2026, analysts expect on average revenue of $2.17B (up 9.7%) and adjusted earnings per share of $2.29 (up 11.9%).
Show more
- MEQIRI Score 68 out of 100 (Neutral): rank 105 of 467 in Basic Materials, median 58.
- The P/E is 33.3 (Chemicals (Specialty) median 24.4, own median of recent years 19.4).
- Our model puts fair value at $56.13, with the price 26% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Reliable dividendNo dividend cut for over 27 years.Capital allocation 69
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 72
- Growing faster than its industryRevenue up 12.8% a year since 2020, Chemicals (Specialty) median 6%.Growth 66
Weaknesses
- Richly valuedP/E 33.3, Chemicals (Specialty) median 24.4, own median 19.4.Valuation 38
Its standout strengths are momentum and technical analysis, while valuation holds the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
What lowers it
- price near its 52-week high
Valuation
Valuation signal
Modestly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $43.18 and expensive above $80.18 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $60.47 (cash-flow model) and $51.79 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 9.6%. At 10.6% the fair value would be $51.30, at 8.6% it would be $62.89.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (24.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Jun 2026, revenue rose 8.1% on the twelve months before. Revenue has grown solidly since 2006, at about 8% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 16%, operating 15%, net 9%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with moderate debt and comfortable interest coverage.
Earnings
- Next earnings
- 1 Apr 2027in 140 days
- Last reported
- 10 Sep 2026EPS reported $1.10
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $2.29−2.7%
- Revenue
- $2.17B−1.8%
- Earnings per share
- $2.56−1.7%
- Revenue
- $2.34B−1.2%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at SOL
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 68
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Hengyi Petrochemical000703.SZ $7.14B54
- Huafon Chemical002064.SZ $6.92B60
- IMCDIMCD.AS $6.72B65
- Shanghai Putailai New Energy Technology603659.SS $6.6B58
- NewMarketNEU $6.42B72
- Fuchs PetrolubFPE3.DE $6.34B74
- Shandong Sinocera Functional Material300285.SZ $6.23B55
- Linde IndiaLINDEINDIA.NS $6.21B63
ETFs that hold SOL
Held by 12 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF DISTLGWU | 0.54% | 0.40% | €575.19M |
| iShares MSCI EMU Small Cap UCITS ETFSXRJ | 0.40% | 0.58% | €834.67M |
| iShares Ageing Population UCITS ETF2B77 | 0.23% | 0.40% | €807M |
Show 5 more
| Xtrackers MSCI Europe Small Cap UCITS ETF 1CXXSC | 0.15% | 0.30% | €3.43B |
| UBS MSCI EMU Select Factor Mix UCITS ETF EUR accUIQN | 0.06% | 0.34% | €16.87M |
| State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR AccZPRX | 0.06% | 0.30% | €810.11M |
| Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF DistX026 | 0.04% | 0.23% | €319.31M |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.03% | 0.45% | €1.53B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 1 May 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.